Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeenath Unnisa

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug and Chemical Toxicology|May 4, 2005
Brain lipid peroxidation and antioxidant status after acute methacrylonitrile intoxicationA Zeenath Unnisa, S Niranjali Devaraj
Indian Journal of Physiology and Pharmacology|May 15, 2008
Effect of methacrylonitrile on membrane bound enzymes of rat brainA Zeenath Unnisa, S Niranjali Devaraj
Biomedicines|February 25, 2022
Gene Therapy Developments for Pompe DiseaseZeenath Unnisa, John K Yoon, Jeffrey W Schindler, et al.
Plos One|July 25, 2015
Deficiency in Aryl Hydrocarbon Receptor (AHR) Expression throughout Aging Alters Gene Expression Profiles in Murine Long-Term Hematopoietic Stem CellsJohn A Bennett, Kameshwar P Singh, Zeenath Unnisa, et al.
Stem Cells International|July 2, 2016
Aryl Hydrocarbon Receptor Deficiency in an Exon 3 Deletion Mouse Model Promotes Hematopoietic Stem Cell Proliferation and Impacts Endosteal Niche CellsZeenath Unnisa, Kameshwar P Singh, Ellen C Henry, et al.
Blood|October 24, 2012
Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stressZeenath Unnisa, Jason P Clark, Jayeeta Roychoudhury, et al.
Blood|March 6, 2015
MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemiaJayeeta Roychoudhury, Jason P Clark, Gabriel Gracia-Maldonado, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Cecilia N Barese, Jeffrey W Schindler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2022
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N Plasschaert, Mark P DeAndrade, Fritz Hull, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2024
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K Yoon, Jeffrey W Schindler, Mariana Loperfido, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug and Chemical Toxicology|May 4, 2005
Brain lipid peroxidation and antioxidant status after acute methacrylonitrile intoxicationA Zeenath Unnisa, S Niranjali Devaraj
Indian Journal of Physiology and Pharmacology|May 15, 2008
Effect of methacrylonitrile on membrane bound enzymes of rat brainA Zeenath Unnisa, S Niranjali Devaraj
Biomedicines|February 25, 2022
Gene Therapy Developments for Pompe DiseaseZeenath Unnisa, John K Yoon, Jeffrey W Schindler, et al.
Plos One|July 25, 2015
Deficiency in Aryl Hydrocarbon Receptor (AHR) Expression throughout Aging Alters Gene Expression Profiles in Murine Long-Term Hematopoietic Stem CellsJohn A Bennett, Kameshwar P Singh, Zeenath Unnisa, et al.
Stem Cells International|July 2, 2016
Aryl Hydrocarbon Receptor Deficiency in an Exon 3 Deletion Mouse Model Promotes Hematopoietic Stem Cell Proliferation and Impacts Endosteal Niche CellsZeenath Unnisa, Kameshwar P Singh, Ellen C Henry, et al.
Blood|October 24, 2012
Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stressZeenath Unnisa, Jason P Clark, Jayeeta Roychoudhury, et al.
Blood|March 6, 2015
MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemiaJayeeta Roychoudhury, Jason P Clark, Gabriel Gracia-Maldonado, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Cecilia N Barese, Jeffrey W Schindler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2022
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N Plasschaert, Mark P DeAndrade, Fritz Hull, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2024
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K Yoon, Jeffrey W Schindler, Mariana Loperfido, et al.
Pageof 1